Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 1 1

Status

Active not recruiting 3

Sponsor Class

NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Breast Neoplasms 10Squamous Cell Carcinoma of Head and Neck 3Oropharyngeal Neoplasms 3Neoplasm Metastasis 3Uterine Cervical Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Pheochromocytoma 2Paraganglioma 2Ovarian Neoplasms 2Multiple Myeloma 2Mouth Neoplasms 2Melanoma 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Cholangiocarcinoma 2Carcinoma, Hepatocellular 2Anus Neoplasms 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Stage III Lung Non-Small Cell Cancer AJCC v7 1Solid Tumor 1Small Cell Lung Carcinoma 1Rhabdoid Tumor 1Rectal Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1

Interventions

Cisplatin 22Magnetic Resonance Spectroscopy 15Specimen Handling 13Platinum 12Radiotherapy, Intensity-Modulated 111,2-diaminocyclohexaneplatinum II citrate 11Radiotherapy 10Radiation 10Carboplatin 9Surveys and Questionnaires 5Biopsy 5pembrolizumab 4Taxes 4Paclitaxel 4Nivolumab 4Docetaxel 4Chemoradiotherapy 4Cetuximab 4Observation 3Fluorodeoxyglucose F18 3(225)Ac-DOTA-c(RGDyK) 3durvalumab 2X-Rays 2Watchful Waiting 2Standard of Care 2Radiotherapy, Image-Guided 2Interviews as Topic 2Immunoglobulin G 2Fluorouracil 2Disulfides 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Oropharyngeal Neoplasms × Fluorodeoxyglucose F18 × 90 days × Clear all
NCT03952585 2026-06-01

De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

National Cancer Institute (NCI)

Phase 2/3 Active not recruiting
384 enrolled 22 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Oropharyngeal Neoplasms

NCT03811015 2026-05-29

Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
636 enrolled
Head & Neck

Oropharyngeal Neoplasms

NCT04533750 2026-04-13

Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin

National Cancer Institute (NCI)

Phase 1 Active not recruiting
21 enrolled
Head & Neck

Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡